Evidence of Non-Standard Material Matrices

Geopolymer-Based Nanoplatform for Targeted Delivery in Glioblastoma Therapy: A Technical Protocol Abstract This study investigates the application of aluminosilicate-based geopolymer matrices, characterized by specific crystalline fingerprints (XRD) and elemental stability (XRF), as a novel therapeutic delivery system for brain tumors. The study proposes a biocompatible, controlled-release protocol utilizing the unique pore-engineering capabilities of geopolymer structures. 1. Methodology & Material Properties Mineral Composition (XRF): Optimized silicate/aluminate ratio for bio-stability. Structural Architecture (XRD): Precisely engineered pore geometry at the nanometer scale, designed for targeted drug encapsulation and localized release within the blood-brain barrier (BBB) environment. 2. Proposed Therapeutic Protocol Encapsulation: Loading of therapeutic agents into the geopolymer nanopores. Targeting: Utilization of surface-modified geopolymer particles to bypass the BBB. Release Mechanism: Passive/Active diffusion controlled by the material’s structural integrity. 3. References & Preceding Documentation This research builds upon the following documented milestones: 10.5281/zenodo.20650359 10.5281/zenodo.20650360 10.5281/zenodo.20650361